Li Chen

Executive Director and CEO, Hua Medicine
· tracked since Aug 2026
Calls
1
Win Rate
0.0%
return
-1.0%
Calls 1 1 Posts tracked · 1.0/day
Calls
7d 1
30d 1
90d 1
Best Calls
No live winners yet
Worst Calls
2552.HK Long -1.0%
Most Mentioned
2552.HK ×1
Recent Calls
2552.HK Long 1 day ago
Win Rate 0% Long 1 Short 0
Win Rate
7d
30d
90d
Average Return -1.0% Long Return -1.0% Short Return -
Average Return
7d
30d
90d
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 21
$2.62
-1.0%
Hua diabetes drug expands hospitals globally.
Hua Medicine's global first-in-class diabetes drug drove 74% revenue growth, with hospital and sales force expansion underway; Hong Kong's one-plus regulatory path and new indications support global scale.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

Li Chen has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026. Most covered: 2552.HK.